Denali Therapeutics Inc. (DNLI)
CA
Total Compensation for Fiscal Year Ending in 2023: $7,879,267
| Salary | $670,000 |
|---|---|
| Bonus | $462,289 |
| Value of Stock Awards | $2,272,291 |
| Value of Option Awards | $4,461,487 |
| Non-Equity Incentive Plan Compensation | $0 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $13,200 |
| Total | $7,879,267 |
Denali Therapeutics Inc. disclosed its CEO pay was
23
times its median employee's pay for the fiscal year ending in 2023.
How Do You Compare?
